Presymptomatic studies in genetic frontotemporal dementia
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Approximately 20% of patients with the neurodegenerative disorder frontotemporal dementia (FTD) have an autosomal dominant pattern of inheritance. Genetic FTD is caused by mutations in three genes in most cases (progranulin, microtubule-associated protein tau and chromosome 9 open reading frame 72) although a number of other genes are rare causes. Studies of other neurodegenerative diseases have shown imaging and biomarker evidence of disease onset many years prior to the development of symptoms. Similar studies in genetic FTD are now revealing evidence of a series of presymptomatic changes, initially in plasma biomarkers followed by MR imaging abnormalities of functional and structural connectivity and then grey matter atrophy. Lastly, neuropsychometric tests become abnormal in proximity to the onset of symptoms. Such studies have been relatively small until now but research centres with an expertise in genetic FTD are now forming consortia such as the Genetic Frontotemporal Dementia Initiative (GenFI) to create larger cohorts that can form the basis of future clinical trials. Les démences frontotemporales (DFT), dans environ 20 % des cas, résultent d’un mode de transmission autosomique dominant. Les trois causes génétiques les plus fréquentes sont des mutations des gènes GRN, MAPT et des expansions hexanucléotidiques au sein du gène C9orf72, alors que d’autres gènes sont plus rarement impliqués. Des études dans d’autres maladies neurodégénératives ont montré que des marqueurs biologiques et d’imagerie du début de la maladie précèdent de plusieurs années les premiers symptômes. Des études similaires concernant les formes génétiques des DFT mettent actuellement en évidence des modifications présymptomatiques, initialement des biomarqueurs plasmatiques, suivies des modifications en imagerie de la connectivité fonctionnelle et structurelle puis des signes d’atrophie de la substance grise. Enfin, les performances aux tests neuropsychologiques deviennent anormales dans la période proche du début des symptômes. Ces études restent peu nombreuses mais les centres ayant une expertise dans la génétique des DFT se regroupent actuellement en consortium tel que l’Initiative pour la Génétique des Démences FrontoTemporales (GenFI) afin de disposer de larges cohortes qui serviront de base au développement des futurs essais cliniques.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · cited 4×
“It remains unclear whether other serum or CSF markers will be abnormal this early as has been found for a number of biomarkers in familial Alzheimer’s disease (Bateman et al., 2012).”
BackgroundInfluentialSelf-citationTabrizi, S. J., Langbehn, D. R., Leavitt, B. R., Roos, R. A., Durr, A., Craufurd, D., Kennard, C., Hicks, S. L., Fox, N. C., Scahill, R. I., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70170-x · Cited by 984 · cited 1×
“Successful models for multicentre consortia of this kind have been established for other neurodegenerative diseases e.g. the Dominantly Inherited Alzheimer’s Disease Network (DIAN) and the TrackHD consortium for Huntington’s disease (Bateman et al., 2012; Tabrizi et al., 2009).”
BackgroundSelf-citationClinical, genetic and pathological heterogeneity of frontotemporal dementia: A review
Seelaar, H., Rohrer, J. D., Pijnenburg, Y. A. L., Fox, N. C., & van Swieten, J. C. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.212225 · Cited by 609 · cited 1×
“Frontotemporal dementia (FTD) is a neurodegenerative disorder usually presenting with either behavioural or language impairment, although it has significant overlap with motor neurone disease (MND) and the atypical parkinsonian disorders (Seelaar et al., 2011).”
BackgroundSelf-citationThe heritability and genetics of frontotemporal lobar degeneration
Rohrer, J. D., Guerreiro, R., Vandrovcova, J., Uphill, J., Reiman, D., Beck, J., Isaacs, A. M., Authier, A., Ferrari, R., Fox, N. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bf997a · Cited by 536
Self-citationClinical staging and disease progression in frontotemporal dementia
Mioshi, E., Hsieh, S., Savage, S., Hornberger, M., & Hodges, J. R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e04070 · Cited by 362
SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Rubino, E., Rainero, I., Chiò, A., Rogaeva, E., Galimberti, D., Fenoglio, P., Grinberg, Y., Isaia, G., Calvo, A., Gentile, S., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e25df · Cited by 286
The Cambridge Behavioural Inventory revised
Wear, H. J., Wedderburn, C. J., Mioshi, E., Williams-Gray, C. H., Mason, S. L., Barker, R. A., & Hodges, J. R. (2008) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642009dn20200005 · Cited by 225
Miyoshi, M., Shinotoh, H., Wszolek, Z. K., Strongosky, A. J., Shimada, H., Arakawa, R., Higuchi, M., Ikoma, Y., Yasuno, F., Fukushi, K., et al. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.04.004 · Cited by 75
Cited by
Rohrer, J. D., Nicholas, J. M., Cash, D. M., van Swieten, J., Dopper, E., Jiskoot, L., van Minkelen, R., Rombouts, S. A., Cardoso, M. J., Clegg, S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70324-2 · Cited by 538
Self-citationBoeve, B., Bove, J., Brannelly, P., Brushaber, D., Coppola, G., Dever, R., Dheel, C., Dickerson, B., Dickinson, S., Faber, K., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.06.4947 · Cited by 61
Remnestål, J., Öijerstedt, L., Ullgren, A., Olofsson, J., Bergström, S., Kultima, K., Ingelsson, M., Kilander, L., Uhlén, M., Månberg, A., et al. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00198-y · Cited by 56
“2008 or Gorno-Tempini et al 2011 [1, 2] and 24 were clinically unaffected participants from the GENFI-study (Table 1) [22, 23].”
BackgroundThe role of neurofilament light in genetic frontotemporal lobar degeneration
Zetterberg, H., Teunissen, C., van Swieten, J., Kuhle, J., Boxer, A., Rohrer, J. D., Mitic, L., Nicholson, A. M., Pearlman, R., McCaughey, S. M., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac310 · Cited by 19
Self-citationExamining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort
Foster, P. H., Russell, L. L., Peakman, G., Convery, R. S., Bouzigues, A., Greaves, C. V., Bocchetta, M., Cash, D. M., van Swieten, J. C., Jiskoot, L. C., et al. (2022) · Cortex · doi:10.1016/j.cortex.2022.01.012 · Cited by 16
Self-citation
Metadata
- Authors
- Rohrer, J. D., Warren, J. D., Fox, N. C., & Rossor, M. N.
- Venue
- Revue Neurologique
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 169
- Issue
- 10
- Pages
- 820-824
- ISSN
- 0035-3787 (ISSN-L)
- OpenAlex
- W1975394589
- Cited by
- 56
- References
- 8
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Presymptomatic studies in genetic frontotemporal dementia. https://app.cochat.ai/papers/10.1016/j.neurol.2013.07.010
- The paper
- Rohrer, J. D., Warren, J. D., Fox, N. C., & Rossor, M. N. (2013). Presymptomatic studies in genetic frontotemporal dementia. Revue Neurologique. https://doi.org/10.1016/j.neurol.2013.07.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.